Search Results
The role of MRD as a prognostic & predictive biomarker in CLL
Biomarker-guided therapy in CLL
Realizing precision haematology in CLL: why we need biomarkers
The expanding role of MRD in CLL
Multiparameter Approach to CLL Diagnosis, Prognostic Biomarker Assessment, and MRD Monitoring
Use of Novel Prognostic Markers in Practice for CLL
FOCUS ON Cytogenomics: Chronic Lymphocytic Leukaemia (CLL) 25th October 2022
Understanding How Biomarkers Help Guide Treatment Decisions for Those with CLL / SLL
Thoughts on the use of MRD in CLL
Prognostic and Predictive Markers in HCC
MRD in CLL: utility from trials to individuals
Future research into MRD-guided treatment of CLL
